Albany, NY -- (ReleaseWire) -- 04/04/2014 -- Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishly. In 2013, China’s pharmaceutical glass bottle market capacity amounted to 80 billion pieces with the weight of 250,000-300,000 tons.
View Full Report With TOC: http://www.researchmoz.us/china-pharmaceutical-glass-packaging-industry-report-2013-2016-report.html
Due to low entry barriers, Chinese pharmaceutical glass market is featured with serious overcapcity of medium and low-end products as well as the reliance of high-end products on imports. At present, developed countries prefer first-class waterproof neutral borosilicate glass, while China still in the main applies low borosilicate glass, sodium-calcium glass and "semi-neutral borosilicate glass" (its chemical stability can not meet neutral requirements; the heavy metal content in glass is not defined clearly; dimensions are not accurate). As for prefilled injection system glass, China mainly relies on the import from foreign brands such as German Schott.
The report involves the following:
20120114.gif Market size, market demand, competition pattern, import & export and development trend of China pharmaceutical glass industry;
20120114.gif Status quo, competition pattern and price analysis of China prefilled syringe industry;
20120114.gif Operation, pharmaceutical glass business and development prospects of four global and six Chinese pharmaceutical glass packaging enterprises.
After years of development and competition, Chinese pharmaceutical glass market concentration degree is still not high, but there have been competitive leading players in some market segments mainly in Jiangsu, Zhejiang and Shandong.
Shandong Pharmaceutical Glass is the world's fifth and China's first medical glass (Class-I) producer. As one of top five Chinese prefilled syringe suppliers, Shandong Pharmaceutical Glass has the capacity of 50 million units/a, but it is still exploring the market with a rather low market share. Meanwhile, the company is a leading pharmaceutical molded bottle enterprise in China with the capacity of 10 billion units/a and about 70% market share.
Find More Reports Related to Pharmaceuticals: http://www.researchmoz.us/pharmaceutical-market-reports-38.html
German Schott has transferred from simple high-end pharmaceutical glass raw material supply to the combination of raw material supply and joint production of finished products. Its joint venture in China -- Schott Xin Kang Pharmaceutical Packaging Co., Ltd. can produce 1-1.5 billion pharmaceutical glass bottles (vials and ampule bottles) each year.
Germany Gerresheimerd conducts Plastic Systems, Moulded Glass, Tubular Glass and Life Science Research in China. However, the prefilled syringes from the company in China are not made in China but imported. In addition, Gerresheimerd and Shuangfeng Glass founded a high-end medical packaging material joint venture -- Gerresheimer Shuangfeng that has two subsidiaries located in Danyang city and Zhenjiang city, as well as three production sites (two in Danyang and one in Zhenjiang).
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Toll Free: 866-997-4948